Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Solid Tumors × relatlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 8 Neoplasms 3 Advanced Cancer 3 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Hodgkin Disease 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Advanced Solid Tumors 1 Advanced Gastric Cancer 1

Interventions

Injections 19 Carboplatin 15 Docetaxel 13 Paclitaxel 9 Bevacizumab 9 pembrolizumab 8 Cisplatin 7 durvalumab 6 Fluorouracil 6 trifluridine tipiracil drug combination 5 tislelizumab 5 linifanib 5 Leucovorin 5 talazoparib 4 olaparib 4 Pemetrexed 4 Nivolumab 4 Itraconazole 4 Irinotecan 4 zimberelimab 3 sintilimab 3 depatuxizumab 3 atezolizumab 3 ST 1481 3 Rifampin 3 Oxaliplatin 3 Gemcitabine 3 Capecitabine 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05498480 2024-02-20

RELATIVITY-111

Bristol-Myers Squibb

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡